Articles Posted in Product Safety

Collinslab-150x150Mukamal-144x150The National Institutes of Health, perhaps the world’s leading medical research institution, has moved fast to try to fix self-inflicted damage to its reputation caused by a controversial $100-million study on alcohol and its harms.

NIH Director Francis Collins halted the study, and an advisory group backed his action, lambasting researchers for soliciting funding and counsel from the alcohol industry for a work that purported to answer key and fundamental questions about booze but from its outset leaned toward seeing benefit in moderate drinking.

The New York Times deserves credit for digging into the dubious  actions by researchers supported by the National Institute on Alcohol Abuse and Alcoholism, an arm of NIH.

ecigopposticker-300x300San Francisco voters, upholding their elected leaders’ enlightened lawmaking, bashed Big Tobacco and its interests, providing a potent primary election message to public health officials nationwide to curb the growing menace to young people posed by e-cigarettes and vaping.

By a 2-to-1 margin, Bay Area residents supported their Board of Supervisors’ tough ban — which may be the most stringent in the nation — on sales of flavored tobacco products, including vaping liquids packaged as candies and juice boxes, and menthol cigarettes.

Specialized liquids, peddled in flavors like bubble gum, chicken and waffles, and unicorn milk, are key to the youth craze for vaping, in which teens use small devices about the size of a computer flash drive to get a nicotine-fueled boost. They can, with standard hits from liquids in devices like the trendy Juul, regularly consume as much nicotine as is found in a pack of cigarettes.

MarijuanaOpioids-300x150There’s been a deadly side to the nation’s opioid drug abuse crisis and increasing number of states’ legalization of marijuana: A leading safety group says the number of drugged drivers killed in car crashes is rising dramatically.

The Governors Highway Safety Association reported that 44 percent of fatally injured drivers tested for drugs had positive results in 2016, which is up more than 50 percent compared with a decade ago, according to a blog post by the nonprofit, nonpartisan Pew Trusts, which added that, “more than half the drivers tested positive for marijuana, opioids or a combination of the two.”

As Pew reported, the District of Columbia and nine states “allow marijuana to be sold for recreational and medical use, and 21 others allow it to be sold for medical use. Opioid addiction and overdoses have become a national crisis, with an estimated 115 deaths a day. States are struggling to get a handle on drugged driving. Traffic safety experts say that while it’s easy for police to test drivers for alcohol impairment using a breathalyzer, it’s much harder to detect and screen them for drug impairment. There is no nationally accepted method for testing drivers, and the number of drugs to test for is large. Different drugs also have different effects on drivers. And there is no definitive data linking drugged driving to crashes.”

catheterablation-300x193It’s one thing when modern medicine becomes so hidebound that it struggles over shedding a bit of traditional doctors’ garb. But new information emerging about cardiology’s entrenched reliance on maverick surgeons and evidence-light therapies in treating heart problems raises real questions: Exactly what’s going on in this costly area of care?

Haider Warraich ── a cardiology fellow at Duke and author of “Modern Death,” a book exploring how technology and modern mores are changing patients’ end-of-life experiences ── deserves praise for raising major concerns about the too easy acceptance by doctors and surgeons of existing, device-based treatments for heart conditions. The headline on his Op-Ed in the New York Times summarizes well his tough point: Don’t Put That in My Heart Until You’re Sure It Really Works.

He, of course, points to recent challenges about the effectiveness of cardiac stents. They have been commonly used for years now ── in hundreds of thousands of surgeries ── supposedly to relieve blockages in patients with stable chest pain. But recent research has started to show they provide no benefit over drugs, and it was only after further study showed that a new kind of dissolving stent contributed to increased heart attack risks that the device maker pulled the already in-use product, Warrich notes.

smoky-300x225It may not come as much more than a duh factor to  nonsmokers with roomies with a heavy cigarette habit, but medical scientists are expressing growing concern about risks posed by “third hand” smoke, residual films left on all manner of environments and surfaces by burning tobacco, close and far.

Multiple media outlets reported on the growing evidence on this potential harm, notably as detailed in a study published in the journal Science Advances. The research, conducted almost by chance, “shows how tobacco smoke from outdoor air can seep into a nonsmoking classroom and coat its surfaces, and how those hazardous chemicals often become airborne again and circulate throughout buildings via central air-conditioning systems,” the Washington Post said.

The newspaper reported that indoor and outdoor air experts at Drexel University in Philadelphia had teamed up and happened to sample surfaces from an empty classroom near their testing lab. They were intrigued to find chemical traces they could not explain, and which they first thought might be tied to coffee spills. But sleuthing led them to determine the residues were from nicotine and tobacco smoke, which only could have been carried into the space by air conditioning or supposed fresh air breezes.

Did you hear it? Was that a giant sigh of relief by Big Pharma executives around the globe? Or was it the air deflating from any Americans who still had high expectations that President Trump, as he had promised for more than a year, really would offer a quick, powerful, and effective public policy prescription to slash skyrocketing drug prices?

The stock market made a big bet that Big Pharma would do just fine, sending drug manufacturer stocks higher.

hitrun-300x248As traffic snarls grow and public transit headaches multiply, commuters in the nation’s capital and elsewhere may be deciding to be healthier and to hoof it or pedal their way to work. But other folks aren’t making alternative means of transportation safer or better for pedestrians or bike riders.

Hit-and-run crash deaths are soaring across the country with walkers and bicyclists victimized in almost 70 percent of the street wrecks, the AAA Foundation for Traffic Safety reported. The foundation said its study has shown that:  “More than one hit-and-run crash occurs every minute on U.S. roads … These resulted in 2,049 deaths in 2016 – the highest number on record and a 60 percent increase since 2009.”

Motorists clearly need to take greater caution and exercise more patience in sharing streets  with those on foot and bikes, foundation officials noted, adding that the need to do so has skyrocketed as more Americans choose for health and other reasons to get around in time-tried ways that also can improve individual wellness.

deductibles-300x199More than 18 million U.S. adults and 6 million children have asthma, a chronic lung disease that inflames and narrows airways and causes recurring wheezing, chest tightness, shortness of breath, and coughing.

How and why Big Pharma jacked up prices for one of the common treatments for this disease tells a key story of not only the difficulty in controlling skyrocketing drug costs but also drug makers’ willingness and capacities to exploit an affliction that costs the country more than $56 billion annually and hits hard at the young, poor, minorities, and the under- or un-insured.

Good Rx, a website led by three technology entrepreneurs who say they want to help Americans with soaring drug costs, deserves credit for reporting on its blog the story of asthma inhalers, and how Big Pharma has kept pushing ever higher the price for them.

odmapapp-150x300Ss the nation’s opioid crisis spirals into ever-more risky territory where synthetic painkillers get mixed with illegal drugs with fatal results, reporters are digging deeper into how drug companies got the country into this mess and cities now are stepping up with different approaches to curb deadly overdoses.

Vox, an online news and information site, reported that experts aren’t sure why, but they’re seeing an ugly trend in users and dealers mixing fentanyl, a synthetic opioid and sometimes legally prescribed painkiller, and other illicit narcotics, notably cocaine and heroin.

Vox reporter German Lopez, in interviews with drug experts, finds they are divided: Some think the deadly mixtures are occurring on purpose, with users seeking even greater intoxication or dealers promoting this to them. It may be that the mixtures are occurring unintentionally, as fentanyl, even in the tiniest amount as a residue, packs a wallop. Or it may be that authorities, as they try to get a better handle on the opioid crisis, have developed sharper data on drug abuses.

eddie-300x169The Food and Drug Administration has cracked down on illegal sales of vaping devices to minors,  taking aim at the suddenly trendy, pricey, and small Juul e-cigarette. But this aggressive regulatory move itself added to criticism of the agency for its failure to clamp down on a key way kids get dosed with nicotine, a highly addictive substance the FDA hopes to slash from tobacco cigarettes.

April, the agency announced, not only has brought showers but also nationwide, month-long undercover raids and citations by enforcement agents for retailers accused of flouting FDA regulations that bar e-cigarette sales to Americans younger than 21.

The FDA also told Juul’s maker that it must produce a raft of documents and explain how and why its product exploded in popularity, dominating in market share and raising questions about how much nicotine users can get from the vaping device — typically as much as a pack of tobacco cigarettes.

Patrick Malone & Associates, P.C. listed in Best Lawyers Rated by Super Lawyers Patrick A. Malone
Washingtonian Top Lawyer 2011
Avvo Rating 10.0 Superb Top Attorney Best Lawyers Firm
Contact Information